Galecto, Inc. – NASDAQ:GLTO
Founder-led company
Galecto stock price today
$3.33
-1.82
-35.34%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
Galecto stock price monthly change
+844.95%
month
Galecto stock price quarterly change
+844.95%
quarter
Galecto stock price yearly change
+621.09%
year
Galecto key metrics
Market Cap | 6.25M |
Enterprise value | 13.78M |
P/E | -0.86 |
EV/Sales | N/A |
EV/EBITDA | -0.22 |
Price/Sales | N/A |
Price/Book | 0.74 |
PEG ratio | 0.04 |
EPS | -1.15 |
Revenue | N/A |
EBITDA | -25.13M |
Income | -30.83M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGalecto stock price history
Galecto stock forecast
Galecto financial statements
Average Price Target
$10
Potential upside: 200.30%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 0 | -10.74M | |
|---|---|---|---|
| Sep 2023 | 0 | -8.13M | |
| Dec 2023 | 1.20M | -6.47M | -538.69% |
| Mar 2024 | 0 | -5.47M |
| 2024-03-08 | -0.31 | -0.23 |
|---|
| Jun 2023 | 58803000 | 15.10M | 25.68% |
|---|---|---|---|
| Sep 2023 | 50049000 | 12.66M | 25.31% |
| Dec 2023 | 38227000 | 5.89M | 15.42% |
| Mar 2024 | 32476999 | 4.31M | 13.3% |
| Jun 2023 | -7.84M | 3.09M | 2.68M |
|---|---|---|---|
| Sep 2023 | -8.45M | 8.28M | 171K |
| Dec 2023 | -11.47M | 9.58M | 0 |
| Mar 2024 | -5.93M | 5.65M | 0 |
Galecto alternative data
| Aug 2023 | 45 |
|---|---|
| Sep 2023 | 45 |
| Oct 2023 | 45 |
| Nov 2023 | 45 |
| Dec 2023 | 45 |
| Jan 2024 | 45 |
| Feb 2024 | 45 |
| Mar 2024 | 13 |
| Apr 2024 | 13 |
| May 2024 | 13 |
| Jun 2024 | 13 |
| Jul 2024 | 13 |
Galecto other data
2.41%
-32.43%
of GLTO is owned by hedge funds
11
-11
611.90K
-8.26M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Apr 2023 | 0 | 238648 |
| Jul 2023 | 0 | 443300 |
| Aug 2023 | 0 | 822680 |
-
What's the price of Galecto stock today?
One share of Galecto stock can currently be purchased for approximately $3.33.
-
When is Galecto's next earnings date?
Unfortunately, Galecto's (GLTO) next earnings date is currently unknown.
-
Does Galecto pay dividends?
No, Galecto does not pay dividends.
-
How much money does Galecto make?
Galecto has a market capitalization of 6.25M. Galecto made a loss 38.35M US dollars in net income (profit) last year or -$0.23 on an earnings per share basis.
-
What is Galecto's stock symbol?
Galecto, Inc. is traded on the NASDAQ under the ticker symbol "GLTO".
-
What is Galecto's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Galecto?
Shares of Galecto can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Galecto's key executives?
Galecto's management team includes the following people:
- Dr. Hans T. Schambye Co-Founder, Pres, Chief Executive Officer & Director(age: 59, pay: $644,980)
- Prof. Bertil Lindmark M.D., Ph.D. Chief Medical Officer(age: 70, pay: $602,630)
- Mr. Anders Pedersen Chief Operating Officer(age: 65, pay: $449,660)
-
Is Galecto founder-led company?
Yes, Galecto is a company led by its founder Dr. Hans T. Schambye.
-
How many employees does Galecto have?
As Jul 2024, Galecto employs 13 workers.
-
When Galecto went public?
Galecto, Inc. is publicly traded company for more then 4 years since IPO on 29 Oct 2020.
-
What is Galecto's official website?
The official website for Galecto is galecto.com.
-
Where are Galecto's headquarters?
Galecto is headquartered at 75 State Street, Boston, MA.
-
How can i contact Galecto?
Galecto's mailing address is 75 State Street, Boston, MA and company can be reached via phone at +45 70 70 52 10.
-
What is Galecto stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Galecto in the last 12 months, the avarage price target is $10. The average price target represents a 200.30% change from the last price of $3.33.
Galecto company profile:
Galecto, Inc.
galecto.comExchange:
NASDAQ
Full time employees:
13
Industry:
Biotechnology
Sector:
Healthcare
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts.
75 State Street
Boston, MA 02109
Boston, MA 02109
CIK: 0001800315
ISIN: US36322Q1076
CUSIP: 36322Q107
